Jennifer Miller
Scoring the Ethics of Pharma Companies
In this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz discuss Harlan’s large new study tracking the trajectory of patient safety in hospitals, and consider how individuals should respond to the latest COVID-19 variants. And they’re joined by Jennifer Miller, a Yale bioethicist and the director of the Good Pharma Scorecard, which evaluates the performance of pharmaceutical companies on measures like the transparency of clinical trials and the accessibility of medicines.
